135
Participants
Start Date
January 31, 2016
Primary Completion Date
December 30, 2020
Study Completion Date
December 30, 2020
Cetuximab plus FOLFIRI/FOLFOX
cetuximab was added into the routine perioperative chemotherapy(FOLFIRI/FOLFOX) to evaluate its safety and efficacy
FOLFIRI/FOLFOX/CapeOX
to evaluate its safety and efficacy of routine perioperative chemotherapy(FOLFIRI/FOLFOX/CapeOX)
Beijing Cancer Hospital, Beijing
Zhejiang Cancer Hospital, Hangzhou
West China Hospital, Sichuan University, Chengdu
First Affiliated Hospital of Kunming Medical University, Kunming
Beijing Municipal Administration of Hospitals
OTHER_GOV
West China Hospital
OTHER
Zhejiang Cancer Hospital
OTHER
First Affiliated Hospital of Kunming Medical University
OTHER
Peking University Cancer Hospital & Institute
OTHER